News Conference News TCT 2021 Good Long-term Results With FANTOM BVS, but More Data Needed Michael O'Riordan October 21, 2021
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News ESC 2018 Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients Michael O'Riordan August 28, 2018
News Conference News EuroPCR 2018 Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents Shelley Wood May 24, 2018
News Conference News SCAI 2018 Interventional Appetite Erodes for Dissolving Polymers and Scaffolds Shelley Wood May 04, 2018
News Conference News ACC 2018 Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
News Conference News EuroPCR 2017 My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not Shelley Wood June 02, 2017
News Conference News EuroPCR 2017 Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis Michael O'Riordan May 19, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate Michael O'Riordan May 15, 2017
News Conference News SCAI 2017 Bioresorbable Scaffolds: Where Do We Go From Here? L.A. McKeown May 15, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Conference News TCT 2015 Novel Devices Present New Treatment Options for STEMI Yael L. Maxwell October 11, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015